MarketScreener Homepage > Equities > Nasdaq > Sage Therapeutics, Inc. SAGE

Report

Delayed Nasdaq - 03/04 04:00:01 pm
70.65	USD		-7.25%

03/02

SAGE THERAPEUTICS : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83, Maintains Equal Weight Rating

02/26

SAGE THERAPEUTICS : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Sets $81 Price Target

02/25

SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, Maintains Outperform Rating

News

Summary

Official Publications

Sector news

Most relevant news about SAGE THERAPEUTICS, INC.

03/02	SAGE THERAPEUTICS : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..	MT
02/26	SAGE THERAPEUTICS : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..	MT
02/25	SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..	MT
02/25	SAGE THERAPEUTICS : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..	MT
02/24	SAGE THERAPEUTICS : Swings to Profit, Posts Higher Revenue in Q4	MT
02/24	SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Resul..	BU
02/24	SAGE THERAPEUTICS : Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..	MT
02/11	SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences	BU
02/10	SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2020 Financial Resul..	BU
02/02	SAGE THERAPEUTICS : Raymond James Reinstates Sage Therapeutics at Market Perfor..	MT
01/22	SAGE THERAPEUTICS : BMO Capital Downgrades Sage Therapeutics to Market Perform ..	MT
01/19	SAGE THERAPEUTICS : Wedbush Adjusts Price Target on Sage Therapeutics to $98 Fr..	MT
01/07	SAGE THERAPEUTICS : Provides 2021 Corporate Strategy Update at J.P. Morgan Heal..	BU
01/04	SAGE THERAPEUTICS : Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, ..	MT
01/04	SAGE THERAPEUTICS : RBC Downgrades Sage Therapeutics to Sector Perform From Out..	MT

More most relevant news

All news about SAGE THERAPEUTICS, INC.

03/02	SAGE THERAPEUTICS : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..	MT
02/26	SAGE THERAPEUTICS : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..	MT
02/25	SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..	MT
02/25	SAGE THERAPEUTICS : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..	MT
02/24	SAGE THERAPEUTICS : Swings to Profit, Posts Higher Revenue in Q4	MT
02/24	SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition..	AQ
02/24	SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ..	AQ
02/24	SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Resul..	BU
02/24	SAGE THERAPEUTICS : Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..	MT
02/11	SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences	BU

More news

News in other languages on SAGE THERAPEUTICS, INC.

2019	Wall Street finit en hausse après une séance hésitante
2019	SAGE THERAPEUTICS, INC. : massacre en vue à Wall Street
2019	AVIS D'ANALYSTES DU JOUR : Air France, BNP Paribas, Teleperformance, DBV Techno..
2019	STOCK MARKET PARIS : La Fed choisit la sobriété
2019	STOCK MARKET PARIS : Et si l'Allemagne aidait la BCE à relancer la croissance ?
2019	EN DIRECT DES MARCHES : Air France KLM, Renault, Vallourec, Scor, Google, Rep..
2019	BB Biotech creuse sa perte au deuxième trimestre
2019	AVIS D'ANALYSTES DU JOUR : Accor, ArcelorMittal, Danone, Novartis, Sika, Sunris..
2019	STOCK MARKET PARIS : La Chine met les Terres Rares dans la balance
2019	AVIS D'ANALYSTES DU JOUR : Hermès, Lagardère, Maurel & Prom, Michelin, TechnipF..

More news

Analyst Recommendations on SAGE THERAPEUTICS, INC.

03/02	SAGE THERAPEUTICS : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..	MT
02/26	SAGE THERAPEUTICS : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..	MT
02/25	SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..	MT
02/25	SAGE THERAPEUTICS : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..	MT
02/02	SAGE THERAPEUTICS : Raymond James Reinstates Sage Therapeutics at Market Perfor..	MT

More recommendations

Press releases

02/24	SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition..	AQ
02/24	SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ..	AQ
02/24	SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Resul..	BU
02/11	SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences	BU
02/10	SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2020 Financial Resul..	BU

More press releases

Upcoming event on SAGE THERAPEUTICS, INC.

05/06/21

Q1 2021 Earnings Release (Projected)

Company calendar

Upcoming sector events

03/10/21	TG THERAPEUTICS, INC. :
03/16/21	DENALI THERAPEUTICS INC. :
03/18/21	ALLAKOS INC. :
03/25/21	EVOTEC SE :

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Biotechnology & Medical Research
			Biotechnology & Medical Research
				Other Biotechnology & Medical Research